Mark S. Freedman
University of Ottawa(CA)Ottawa Hospital(CA)Ottawa Hospital Research Institute
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Sphingolipid Metabolism and Signaling, T-cell and B-cell Immunology, Neurogenesis and neuroplasticity mechanisms, Neuroinflammation and Neurodegeneration Mechanisms
Most-Cited Works
- → Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein(2007)407 cited
- → Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension(2018)329 cited
- → Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study(2013)232 cited
- → Peripheral blood γ‐δ T cells lyse fresh human brain—Derived oligodendrocytes(1991)130 cited
- → Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases(2016)102 cited
- → NKG2D-Mediated Cytotoxicity toward Oligodendrocytes Suggests a Mechanism for Tissue Injury in Multiple Sclerosis(2007)101 cited